Skip to content

Clinical trials

Phase 1/2 Lymphoma, B-Cell, Marginal Zone trials with unknown status

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Lymphoma, B-Cell, Marginal Zone Phase: Phase 1/2 Status: Unknown status Clear all

3 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20051
20141

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Unknown status3

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Jichi Medical University1
LifeTime Pharmaceuticals1
Technical University of Munich1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Lymphoma3
Lymphoma, B-Cell, Marginal Zone3
Lymphoma, Follicular3
Lymphoma, Mantle-Cell2
Lymphoma, Non-Hodgkin2
Burkitt Lymphoma1
Immune System Diseases1
Leukemia, Lymphocytic, Chronic, B-Cell1
Lymphoma, B-Cell1
Lymphoma, Extranodal NK-T-Cell1

Trials

Showing 1 to 3 of 3. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.